|
|
Article: Nabi Biopharmaceuticals Receives Second U.S. Patent Covering Staphylococcus Aureus Vaccine for Mastitis and Other Veterinary Uses.
- Article from:
- PR Newswire
- Article date:
- March 27, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Nabi Biopharmaceuticals today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 6,537,559 entitled "Staphylococcus aureus antigen-containing whole cell vaccine." This patent covers the composition of a S. aureus vaccine, the method of vaccine preparation, immunotherapy and its use as a therapeutic or prophylactic agent to protect animals against infection. The Staphylococcus aureus vaccine, as detailed in the patent, specifically covers the incorporation of whole cells, cell lysate, cell derivatives and antigens obtained from the three significant bacterial strains (types 5, 8, and 336) that comprise nearly all of the S. aureus isolates ...